| no VR | VR | p-value |
n | 50 | 49 |
|
% female | 54% | 49% | 0.383 |
Beta blocker | 28% | 26.50% | 0.525 |
Pacemaker | 14% | 14.30% | 0.597 |
Used VR in the past | 18% | 16.30% | 0.518 |
Type surgery |
|
| 0.251 |
upper extremity | 34% | 41% |
|
torso | 26% | 35% |
|
lower extremity | 40% | 24.50% |
|
Nausea | 2% | 4% | 0.492 |
Vomiting | 0% | 0% | NA |
Dizziness | 4% | 6% | 0.49 |
Seizures | 0% | 0% | NA |
will VR use again | 14% | 96% | *<0.0001 |
Satisfaction |
|
| *<0.0001 |
1 | 0% | 2% |
|
2 | 2% | 0% |
|
3 | 10% | 4% |
|
4 | 56% | 8% |
|
5 | 32% | 86% |
|
age | 43 (range 18 - 86) | 48 (range 19 - 87) | 0.165 |
Charlson | 3 (range 0 - 20) | 3 (range 0 - 10) | 0.581 |
Surgery time | 28.5 (range 17 - 43) | 24 (range 17 - 57) | 0.659 |
Pre pain | 0 (range (0 - 5) | 0 (range (0 - 5) | 0.818 |
Pre anxiety | 4 (range 0 - 10) | 5 (range 0 - 10) | 0.535 |
Pre systolic BP | 130 (range 110 - 150) | 143 (range 112 - 173) | *<0.0001 |
Pre diastolic BP | 76 (range 54 - 90) | 79 (range 56 - 92) | 0.242 |
Pre HR | 74 (range 50 - 92) | 76 (range 56 - 93) | 0.588 |
half pain | 0 (range (0 - 1) | 0 (range (0 - 2) | 0.69 |
half anxiety | 0 (range (0 - 2) | 0 (range (0 - 2) | *0.02 |
half systolic BP | 130 (range 114 - 155) | 136 (range 120 - 156) | *0.001 |
half diastolic BP | 79 (range 55 - 90) | 75 (range 58 - 88) | *0.047 |
half HR | 78 (range 54 - 98) | 70 (range 55 - 88) | *0.003 |
End pain | 0 | 0 | NA |
End anxiety | 0 | 0 | NA |
End systolic BP | 127 (range 109 - 148) | 132 (range 112 - 155) | *<0.0001 |
End diastolic BP | 72 (range 55 - 88) | 72 (range 57 - 85) | 0.459 |
End HR | 76 (range 52 - 90) | 69 (range 54 - 86) | *0.071 |